$17.73 +0.19 (1.08%)

Biohaven Ltd. (BHVN)

Biohaven Ltd. is a biopharmaceutical company focused on developing and commercializing innovative medicines for neurological and neuropsychiatric disorders. Known for its research in neuroscience, it has developed treatments targeting conditions such as migraines, neurodegenerative diseases, and other CNS disorders. The company emphasizes scientific innovation and the advancement of therapies to improve patient outcomes.

🚫 Biohaven Ltd. does not pay dividends

Company News

Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform
GlobeNewswire Inc. • Zvonimir Vrselja, M.D., Ph.D. • October 15, 2025

Bexorg, a biotech startup, secured $42.5M in funding to develop an AI-powered platform for central nervous system drug discovery using whole human brain data, aiming to reduce the historically high clinical trial failure rates in CNS drug development.

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga • Benzinga Staff Writer • September 29, 2025

Multiple health care stocks experienced significant options trading activity, with various bullish and bearish signals across different companies in the sector.

Why Biohaven Stock Zoomed More Than 6% Higher Today
The Motley Fool • Eric Volkman • August 22, 2025

Biohaven's stock rose over 6% after the FDA indicated an advisory committee meeting was unnecessary for its New Drug Application for troriluzole, a drug targeting spinocerebellar ataxia. Research suggests this could signal potential drug approval.

Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
Zacks Investment Research • Zacks Equity Research • May 30, 2024

Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.

Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky
MarketWatch • MarketWatch • December 28, 2023

Investors should consider this list of healthcare stocks for 2024